Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

Zacks #1 Stocks on the Move 05/21/2013

Company Name Symbol %Change
SCIENTIFIC L SCIL
8.00%
SUMMER INFAN SUMR
6.63%
RADIANT LOGI RLGT
6.38%
FEDERAL MOGU FDML
5.99%
NEW ORIENTAL EDU
5.54%
 
 

TODAY'S TOPICS

1. ZACKS EQUITY RESEARCH: Even a short period with a negative spread can make for an ugly couple quarters for large-cap banks. Read the analyst interview and get our Bull and Bear of the Day.

2. PROFIT TRACKS: Recent Price Strength: Find companies with healthy earnings through this screening method.

3. ZacksAdvisor.com TIMELY BUY of the WEEK: AstraZeneca has a solid record of beating consensus earnings estimates, and momentum is likely to continue.

4. FEATURED EXPERTS: Richard Moroney suggests that it is not yet time to panic. Learn about core inflation and check out some Buy List stocks.

- - - - - - - - - - - - - - - - - - - - -

Twelve times more profitable than owning Apple at the beginning of the iPod craze...

If you had bought Apple at $10.45 last October before the iPod took off and held until today, you'd be sitting on 410% gains!

But that's chump change. These 3 stocks are poised to hand you 14.34 times Apple's home-run performance. A buy now virtually locks in gains as early as November 22 or your money back - guaranteed. Learn more!
 

Thursday - November 10, 2005

Want to view the archive of past issues? Go to: http://at.zacks.com/?id=2337.

Manage Profit from the Pros subscription:
* Free Subscription: http://at.zacks.com/?id=2338
* Change of address: http://at.zacks.com/?id=2339
* Unsubscribe: http://at.zacks.com/?id=2340
 

1. ZACKS EQUITY RESEARCH

Back to top

Our senior analyst covering large-cap banks, Scott Jaggers, CFA, has given us some helpful words regarding what incremental interest rate increases from the Fed has done for the banking industry. For this and more on the topic of banks, we had him answer some of our specific questions.

How is the banking industry being impacted by the recent Florida hurricanes?

If we look at forecasting assigning multiples to come up with a price of how much these storms are costing banks in Florida…the main thing to take away from this is that everyone is disregarding Wilma and Alpha as one-time items. After Hurricane Katrina hit the Gulf Coast, perhaps certain banks made special loan provisions for the third quarter, depending on the size of the bank, for expected losses that have yet to materialize. Of course, for any banks with significant financial problems before the storms hit, this would be a different story. But no companies in my coverage fall under this category. Also, Hurricane Wilma was not as devastating as Hurricane Katrina, and even so, if third quarter earnings wind up missing estimates by a penny or two, no one’s going to be too concerned about it.

Perhaps Florida banks with branches in other areas can take up the slack?

Sure. These things shift around. Banks are big on insurance, and most lease their facilities anyway, so nobody’s going to really lose out if a few branches in Florida get destroyed. Keep in mind I’m still referring to the large-cap banks in my coverage; a small bank with its entire livelihood in, say, Key West might actually have some real problems. For banks in my coverage, though, people still have to do their banking, so if a bank shuts down, the customer will track down a different branch and do his business there.

Again, the situation in New Orleans is the one that might have a serious negative impact. If that city doesn’t come back strong--which I simply just can’t imagine, personally--you may see banks located there experiencing lots of trouble. Perhaps banks in New Orleans would need to transfer business to somewhere in Texas, say. Then again, if New Orleans grows as big or even bigger than it was previously, many banks could do exceptionally well. Building in the region would take money, so loans would increase as development there would take place. So that’s a real wild card down there.

More. . .

 
WHAT’S 45 MINUTES WORTH TO YOU?

It could be the best investment you’ll ever make.

Free Webinar - INVEST 45 MINUTES AND YOU WILL LEARN:

  • How to make High Returns like a top investor
  • How to average 50% (or better) ROI per trade
  • How to adjust trades to turn losers into winners
  • Proven methods to pick the right stocks
  • How to make up to 1300% annual returns in a Flat Market

Time is Money!
To see if you qualify for this Webinar, click here.
 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Back to top

 
Zacks Equity Research continued...

We are more concerned about what will be the long-term impact to the economy from the hurricanes. Although most lodging companies have been very forthcoming on the impact from property disruptions and damage, we remain concerned about the consumer psyche. Consumer confidence has plunged, and it remains to be seen how pricing can hold up if demand falters heading into 2006. A tightening of budgets by businesses in an inflationary environment would also likely put a crimp on occupancy and pricing for the industry. That being said, we believe these risks have largely been priced into the lodging companies, which are now trading at much lower multiples than just a few months ago.

Again, the situation in New Orleans is the one that might have a serious negative impact. If that city doesn’t come back strong--which I simply just can’t imagine, personally--you may see banks located there experiencing lots of trouble. Perhaps banks in New Orleans would need to transfer business to somewhere in Texas, say. Then again, if New Orleans grows as big or even bigger than it was previously, many banks could do exceptionally well. Building in the region would take money, so loans would increase as development there would take place. So that’s a real wild card down there.

As far as Florida goes, though, we clearly see extra losses in the near term, which everyone will disregard. Money will come in from the insurance companies, too, which is also a good thing. Bottom line: everybody seems to be talking about this issue, but it’s not making much of an impact, at least for banks in our coverage.

What do you feel is the biggest issue regarding large-cap banks right now?

Interest rates remain a key discussion. We continue to expect additional rate increases from the Fed at this point, with Fed Funds rising to 4% by year's end, then perhaps a slowing pace after that, rising to perhaps 4.5% by the first quarter '06. Expectations are key, as banks can manage interest rates more effectively when they can predict them. Outgoing Fed Chair Greenspan’s slow-and-steady approach has been good for margins overall, and his expected replacement, Ben Bernanke, I think can be counted on to be on board with this approach. The shape of the yield curve has been problematic for most, however. The Fed can control the short end of the curve with some precision, but the market clearly sets the long end. At this point, short rates have been rising for a year and a half, with Fed Funds up a 325 basis points. The long end has not followed suit, though, and the curve has flattened dramatically. The spread between 90-day bills and 10-year bonds is currently about 60 basis points (bps), versus a 340 bps average in June of 2004. While this is lower than the 20-year average of 180 bps, it could clearly get worse--the slope was negative as recently as early 2001. It's very hard to predict, but you never know--we may get an inverted curve or a flat curve for a short time. For each of the three times over the past 20 years there has been a negative spread, it only happened for a very short time each time. But even a short period with a negative spread can make for an ugly quarter or two.

Looking at the longer-term, it seems credit quality has kept up quite well. What's your take on this?

Actually, credit quality has been amazingly good for several quarters in a row now. In my model--and I know I'm not alone in doing this--I draw this hockey stick that I keep pushing out further with every good quarter. We're all doing it, all of us analysts, even though we're well aware that the drop-off is definitely coming at some point.

Well, now with Sarbanes-Oxley legislation, banks are no longer being allowed to smooth earnings over time. One of the main points of this law was to keep companies from hiding assets and smoothing their earnings, but for banks, smoothing credit through loss provisions has always been a legitimate GAAP practice. Banks are unique in doing this. It's one of the reasons a company like Bank of America (BAC) could normally charge off $1 billion and not have it show up on the company's income statement. But Sarbanes-Oxley auditors have gotten much more rigorous--they now say banks can't record loss provisions without directly attributing them to specific loans.

Therefore, when losses start coming in, the charge-offs will have to be made up with larger provisions rather than smaller ones. Banks that have done surprisingly well lately might surprise to the negative going forward, when earnings might realistically suffer for a time until provisions can be put back on the books. This would lead to analysts not being able to tell if their forecasts are too high or too low. I read an article by a pretty well-known analyst lately that said banks are going to get clobbered due to this, and that estimates are currently 5-10% too high.

From what I've seen so far, this looks to be true. Provisions seem to have gone up across the board. And for banks with heavier commercial loan concentration--which usually get higher valuations than those with higher mortgage concentration--their losses might be much, much bigger if they can't reserve funds for smoothing earnings. Investors should be aware of what impact this may have, and act accordingly. For me, I'm expecting the drop in credit quality to come a bit sooner now because of this; I don't think I'll be pushing out that hockey stick going forward.

Scott Jaggers, CFA is a Zacks senior analyst covering large-cap banks and the finance industry.

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Back to top

 
MORE FROM ZACKS EQUITY RESEARCH...
 

BULL OF THE DAY

TRM Corp. (TRMM) - Consolidating ATM Market. For full Zacks research report, click here.

 
BEAR OF THE DAY

Pogo Producing (PPP) - Lacking Organic Growth Prospects. For full Zacks research report, click here.

 
EARNINGS & SECTOR UPDATE

In the Homestretch

Dirk Van Dijk, Director of Research for Zacks Equity Research, says the S&P 500 is expected to post double-digit growth for both 2005 and 2006: http://at.zacks.com/?id=2343.

 
ZACKS INDUSTRY OUTLOOK

Industry Rank for the Week of November 7

Margins are rising for cable and wire companies, but retailers are relying on promotional pricing: http://at.zacks.com/?id=2344.
 

 
Learn More about Zacks Equity Research at http://at.zacks.com/?id=2268.

Full access to Zacks Equity Research reports is only available with a subscription to the Zacks Advisor. Besides the articles noted above you will also discover:

  • 1150 In-Depth Company Research Reports with Recommendations
  • Economic Outlook & Market Strategy Reports
  • Zacks Focus List (stocks for the long term)
  • Zacks Timely Buys List (stocks for the short term)

To learn more about ZacksAdvisor.com and the free trial offer, click here.
 


2. PROFIT TRACKS

Back to top

Zacks.com is proud to share with you some of the best trading strategies that truly allow you to Profit from the Pros. Today we highlight…

 
Profit Tracks: Earnings and Margins

This Profit Track goes to the heart of fundamental investing by finding companies with healthy earnings. The main ingredients are the search for Earnings Growth and Net Profit Margins. Then for good measure we make sure earnings estimates are moving higher which is a strong indicator of future performance and that brokerage firms are positively rating the stock.

Earnings are the single most important metric for a company. Combine that with a healthy Net Profit Margin and you find a screen that has generated a cumulative return of +425% since January 2001. During the first half of 2005, this screen continued its winning ways with a +13.8% return.

 
Here are four stocks that make the grade for the Earnings and Margins Profit Track:

Advisory Board Co. (NASDAQ: ABCO) reported fiscal second-quarter earnings in late October. The result topped last year’s second quarter and matched the consensus estimate. The company noted that its performance was driven by cutting-edge research agendas and continued program innovation, which led to strong renewal performance and continued growth across ABCO’s program portfolio. The company, which has a net margin of .16, managed to produce annual earnings growth of about 15% above the previous year. To continue your research on ABCO, click here.

AAR Corp. (NYSE: AIR) generated impressive earnings growth of 400% last year over the previous year. The company, a worldwide leader in supplying aftermarket products and services to the global aerospace/aviation industry, reported fiscal first-quarter earnings of 15 cents per share in late September. The result surpassed the consensus estimate by about 7% and eclipsed last year's first-quarter earnings. The company stated that sales and earnings growth for the quarter were driven by increased sales in the Aviation Supply Chain, Maintenance, Repair & Overhaul and Structures & Systems segments. To continue your research on AIR, click here.

Champion Enterprises, Inc. (NYSE: CHB) posted third-quarter earnings of 20 cents per share in mid-October, matching analysts’ expectations and outperforming the year prior total. The company stated that the third quarter was marked by continued progress toward attaining its goals of improved margins and modular growth. CHB experienced earnings growth of almost 120% for its most recently completed year versus the previous year. To continue your research on CHB, click here.

Western Sierra Bancorp (NASDAQ: WSBA) is a profitable company as evidenced by its net margin of .20. WSBA has also demonstrated solid year-over-year growth with the full year 2004 posting earnings growth of nearly 20% above the year prior. In mid-October, the company announced GAAP earnings of 59 cents per share for the third quarter. The result improved on last year’s 49 cents and outpaced the consensus estimate by almost 2%. To continue your research on WSBA, click here.

 
To see the full list of stocks that currently pass this winning screen, go to: http://at.zacks.com/?id=2358.

All the Profit Track strategies were created and backtested using the Research Wizard software from Zacks Investment Research. If you like this screening strategy, but want to narrow down the list of stocks and even improve the performance, then you should start a free trial to this powerful stock picking tool. Learn more about the Research Wizard free trial offer and our new special report “Top 10 Stock Screening Strategies” at: http://at.zacks.com/?id=2359

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

 
SCREEN OF THE WEEK

Creating a Custom Consensus of your Winningest Screens

Kevin Matras combines some of his winningest strategies to create a Custom Consensus screen: http://at.zacks.com/?id=2360.
 


3. ZacksAdvisor.com TIMELY BUY of the WEEK

Back to top

Here you`ll discover a Zacks #1 Ranked stock hand selected by Ben Zacks to outperform the market over the next 30 to 90 days. This week`s Timely Buy is…
 

AstraZeneca (AZN)

AstraZeneca (AZN) engages in the research, development, manufacture, and marketing of prescription pharmaceuticals, as well as the supply of healthcare services worldwide. It provides medicines designed to fight disease in areas of medical need, such as cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory.

Perhaps the strongest of all AstraZeneca drugs is Seroquel (for schizophrenia). Seroquel continues to gain market share against its chief competition Zyprexa (Eli Lilly), Risperdal (Johnson & Johnson), and Geodon (Pfizer). The U.S. Food & Drug Administration (FDA) approval the drug last year for bipolar I disorder (recurring episodes of mania and depression), and an increased dosing cycle approval to a 12-week regimen. We are optimistic on future trends for Seroquel throughout 2005. The company will likely ring up total sales of nearly $2.7 billion in 2005, growing to over $4 billion in 2008

More...

 
Top Ten Stocks for 2006 from Leading Investment Experts

Get your complimentary copy of NewsletterAdvisors.com’s 14-page special report with ten stock picks from investment experts including the Motley Fool, Louis Navellier, Bernie Schaeffer, Ian Wyatt, and Neil George among others. Get your copy of the free report today. Just click here now.
 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Back to top

 
TIMELY BUY of the WEEK continued...

Recent third quarter 2005 earnings were above expectations. The company said its net profit for the three months to Sept. 30 came to US$1.23 billion (euro1.02 billion) over the three months to Sept. 30, up from US$1.14 billion a year ago. Revenue rose to US$5.8 billion (euro4.83 billion) from US$5.6 billion as sales of its five key products -- Nexium, Crestor, Symbicort, Arimidex and Seroquel -- increased by a combined 25 percent. AstraZeneca said it now expects earnings per share for the full year between $2.85 and $2.95.

Valuation is highly attractive given the superior growth rate. We see AstraZeneca being able to deliver a four year CAGR of 16.4%, significantly above that of all other large-cap pharmaceuticals (ex. Schering-Plough). Strong bottom-line growth is driven by a combination of growing revenues, moderating operational costs and aggressive share buybacks. The stock currently trades at 16.3x 2005 EPS, about a 10% premium to the peer-group. However, given the expected 16% growth in 2006 we believe that AstraZeneca still offers upside the remainder of the year. The shares will begin to trade at a discount to the peer-group in late 2006/early 2007 unless the shares move to above $50.

The company is also working on reducing costs to drive profitability beyond 2005. AZN should continue to see selling, general and administrative (SG&A) costs decline as a percent of total revenue for the next several years. Additionally, gross margins should continue to expand, given the ramp in key blockbuster products. Share buy-backs are also a significant driver of the bottom-line. The company has $3 billion in buy-backs authorized for the next year.

The company has a solid record of beating consensus earnings estimates. Over the past four quarters, AZN has come in ahead of expectations each time. They surpassed views by anywhere from 1% to 41%. Given the magnitude of their recent earnings beat, it is likely that this momentum will continue for the next few quarters. When a company this large exceeds expectations by such a big amount, it is worthwhile to take notice.


 
About Zacks Timely Buy of the Week

Each week we highlight one stock from the ZacksAdvisor.com Timely Buys list. This exclusive portfolio selected by Ben Zacks has beaten the S&P 500 every single year since inception in 1996. $10,000 invested in this strategy since inception would now be worth $104,294 versus only $22,515 invested in the S&P 500. And in 2005 (through September 30), this strategy is up +8.69% versus just +2.73% for the S&P 500.

Click here to learn more about ZacksAdvisor.com and the free trial offer.
 


4. FEATURED EXPERTS

Back to top

Here we cast the spotlight on a timely Featured Expert commentary that recently appeared on Zacks.com. Following the article you will find previews of other profitable commentaries with insights and recommendations from leading investment experts.

 
a) Richard Moroney, Editor of the Dow Theory Forecasts newsletter
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Back to top

Inflation hits highest level since 1991! Oil prices hover above $60 per barrel! Gold prices continue to rise!

A quick glance at newspaper headlines may leave you with the impression that blood is running in the streets. While the statements above are correct, they should not yet drive you to panic.

Energy prices get plenty of press, but energy represents less than 8% of all consumer spending. Energy prices rose 12% from August to September, driving the Consumer Price Index (CPI) up 1.2% for the month. The 4.7% year-over-year increase in CPI represented the biggest jump since 1991. But core inflation, which excludes the effects of food and energy rose a modest 2% year-to-year in September.

Inflation reduces the purchasing power of money, making it harder for consumers to buy goods and services, and for businesses to expand. Over the last decade, inflation averaged 2.5%, versus the 30-year average of 4.4%.

Economists continue to debate the root cause of inflation. While experts have put forth many conflicting theories about what makes prices rise, everyone seems to agree that inflation affects consumers and producers at all levels of the economy.

Inflation is usually measured by observing changes in prices of a basket of goods and services. The most commonly cited U.S. inflation measure is the Consumer Price Index (CPI), which reflects the price of hundreds of items purchased by the average household.

While the CPI reflects changes in the prices of common goods and services purchased by consumers, the Producer Price Index for Finished Goods (PPI) represents the average change in the price of finished goods sold by producers to other businesses.

In September, spikes in energy and food prices drove the PPI up 6.7% from the year-earlier period, the largest increase in nearly 15 years. While the PPI excluding energy and food rose just 2.5% in September, any sustained increases in energy or food prices could pass through into other sectors, which could in turn exert upward pressure on overall wholesale and retail prices.

The PPI does not reflect labor costs, which represent about two thirds of production costs. Compensation costs rose 3% in the September quarter, the slowest growth since the March 1999 quarter.

Why should investors pay attention to inflation? Because it directly affects their returns. Stocks have historically performed better during periods of low inflation, and inflation erodes all investment returns by reducing the purchasing power of future cash flows. Some other financial phenomena associated with inflation are detailed below:

  • Rising interest rates. Higher interest rates drive up the cost of borrowing, potentially stifling business investment. Higher rates also make debt investments more attractive relative to stocks, which can push investors to sell equities.
     
  • Lower P/E ratios. Stocks are priced based on the value of future profits. Inflation reduces the present value of those profits, thus reducing the value of stocks.
     
  • Lower profit growth. Company cash flows may not be able to fund as much investment in the business.
     
  • Negative perceptions and uncertainty. Both businesses and consumers often perceive higher inflation as an indicator of increased risk. Inflation tends to be more volatile when it rises, making it difficult for companies to plan for the future.

To control inflation, the Federal Reserve on Nov. 1 raised short-term interest rates for the 12th time since June 2004. In its October meeting, the Fed raised its inflation forecasts, citing high energy prices in the near term and a rise in economic growth next year during the rebuilding process.

Recent CPI and PPI data suggest a modest buildup of inflationary pressures. A substantial rise in core inflation would be cause for concern, and Richard Moroney and his team intend to watch the data closely. But the Fed appears willing to continue raising interest rates, and core inflation is unlikely to rise above the 30-year average of 4.4%.

 
A Sampling of the Long-term Buy List

Citigroup (NYSE: C) the preeminent global financial services company with some 200 million customer accounts in more than 100 countries, provides consumers, corporations, governments and institutions with a broad range of financial products and services, including consumer banking and credit, corporate and investment banking, insurance, securities brokerage, and asset management.

Coventry Health (NYSE: CVH) is a managed health care company operating health plans under the names Coventry Health Care, Coventry Health and Life, HealthAmerica, HealthAssurance, HealthCare USA, Group Health Plan, SouthCare, Southern Health, Carelink Health Plans, and WellPath. The Company provides a full range of managed care products and services including health maintenance organization, point-of-service, preferred provider organization products, and Medicare and Medicaid products. The Company also administers self-insured plans for large employer groups.

Energen (NYSE: EGN) is a diversified energy holding company engaged in natural gas distribution and oil and natural gas exploration and production activities. The Corporation's utility subsidiary, Alabama Gas Corporation, is the largest natural gas distribution utility in the State of Alabama. The Corporation's oil and gas exploration and production activities are conducted by its subsidiary, Taurus Exploration, Inc. and its subsidiary.

 
About Richard Moroney’s Dow Theory Forecasts newsletter

Get clear Buy, Hold and, yes, SELL advice from one of the nation’s oldest and most successful investment newsletters. Our in-depth analysis and advice have been helping subscribers weather market volatility since 1946. http://at.zacks.com/?id=2406.
 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Back to top

 
MORE FEATURED EXPERTS...

b) Back on Track

John Reese says the Hot List is easily outpacing the market’s gains since the last newsletter issue. More...
 

c) Staging a Comeback

Dr. Edward Olmstead believes the market will attempt to challenge the 2005 highs. Discover his option play of the month. More...
 


OTHER TOOLS FROM ZACKS

Back to top

At the heart of Zacks Investment Research is the Zacks Rank investment philosophy that continues to vastly outperform the market. Our Zacks #1 Rank (Strong Buy) List has produced the following results for investors:

  • +33% average annual return since 1988 versus +11.8% for S&P 500
  • Outperformed S&P 500 in 16 of the last 17 years
  • +43.8% total return from 2000 to 2002 - the worst bear market in over 60 years.
  • +18% in 2005 (through September 30)

And just as importantly, our #5 Ranked stocks (Strong Sells) have alerted investors as to which stocks to dump from their portfolios to avoid unnecessary losses.

To truly take advantage of the Zacks Rank, you need to first understand how it works. That's why we created the free special report; Zacks Rank Guide: Harnessing the Power of Earnings Estimate Revisions. Download a free copy now to prosper in the years to come, by visiting: http://at.zacks.com/?id=2350.

Or view the full list of Zacks #1 Ranked stocks at: http://at.zacks.com/?id=2351.

FREE PORTFOLIO TRACKER

Do you believe that these events affect stock prices?

  • Broker Recommendation changes
  • Earning Estimate revisions
  • Earnings Announcements
  • Zacks Rank changes

If you answered yes, then how are you staying on top of these changes for your stocks? If you are one of the 45,000 investors who wake up every morning to the Daily Portfolio Updates emails from Zacks.com, then you are all set. If not, then sign up now to get this vital information sent to you daily to help take definitive action to improve your portfolio's performance. Did we mention it's free? Get started now!


We hope you enjoyed this issue of "Profit from the Pros", And we look forward to visiting with you again next week.

REFER-A-FRIEND

If you enjoy this e-mail newsletter, then please pass it along to a friend. Simply forward them the link below to sign up for their own free subscription. If you're reading a forwarded copy, sign up for your own, so you get this wealth of information every week. Just click here. THANKS!

Regards and Happy Investing,

Charles Rotblut, CFA

Senior Market Analyst
Zacks.com

p.s. What is the mission for Zacks Profit from the Pros? Click here to find out how we will help you become a more successful investor.


*The S&P 500 Index is a well-known, unmanaged index of the prices of 500 large-company common stocks, mainly blue-chip stocks, selected by Standard & Poor's. The S&P 500 Index assumes reinvestment of dividends but does not reflect advisory fees. An investor cannot invest directly in an index.

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.

To contact us by mail:

Zacks Investment Research
Attn: Profit from the Pros
155 N. Wacker Drive, 6th Floor
Chicago, IL 60606

To unsubscribe from receiving "Profit from the Pros" e-mail newsletter, click here.


 

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.